Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bouncing Metformin Intervention (BMI) Study
2021-005568-23Phase 3Active
- Sponsor
- Bethesda Diabetes Research Center
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Bethesda Diabetes Research Center. Primary endpoint: Metabolic outcomes. Started Dec 2021; status: active.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2021-005568-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005568-23.